Background: Extracorporeal photopheresis (ECP) has been considered for treatment of patients with systemic sclerosis (SSc).
Objectives: To study the 12-month effects of ECP on laboratory parameters and evaluate the SSc-related long-term survival.
Methods: 59 SSc patients who had received at least 6 ECP cycles were included.